NEW YORK (GenomeWeb) – Though researchers and diagnostic development firms have for some time been exploring using exosomes — persistent, circulating vesicles that carry cellular nucleic acids and proteins — for cancer and other disease testing, the field has yet to see many tests translated into clinical use.

Much work has been focused on isolating the full spectrum of exosomes circulating in a blood sample, and then searching their RNA or DNA en masse for cancer biomarkers.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.